Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis

Tomomitsu Tahara, Tomiyasu Arisawa, Tomoyuki Shibata, Hiromi Yamashita, Daisuke Yoshioka, Ichiro Hirata

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: The altered expression of multidrug resistance 1 (MDR1) contributes to various types of carcinogenesis and their disease progression. Hypermethylation of CpG islands located in the promoter regions is involved in gene silencing at the transcriptional level. The methylotion status of MDR1 gene promoter was investigated in gastric cancer in relation to various clinicopathological features. Patients and Methods: The methylation of the MDR1 promoter was estimated in both antral non-neoplastic mucosa and cancer lesions in 83 patients with gastric cancer using a methylation-specific PCR method. Results: The methylation ratio (MR) of the cancer lesions (31.3±20.5) was significantly higher than that of non non-neoplastic mucosa (20.9±31.3, p=0.0004). The MR was especially high in Lauren's intestinal cancer (p<0.0001). A higher MR was also observed in more advanced stage (p=0.005) and lymph vessel invasion-positive cases (p=0.002). Conclusion: The promoter methylation of MDR1 seems to have a significant role in carcinogenesis and tumor progression in the stomach.

Original languageEnglish
Pages (from-to)337-341
Number of pages5
JournalAnticancer research
Volume29
Issue number1
Publication statusPublished - 01-01-2009

Fingerprint

MDR Genes
Methylation
Stomach
Carcinogenesis
Multiple Drug Resistance
Stomach Neoplasms
Mucous Membrane
Intestinal Neoplasms
Neoplasms
CpG Islands
Gene Silencing
Lymph
Genetic Promoter Regions
Disease Progression
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Tahara, T., Arisawa, T., Shibata, T., Yamashita, H., Yoshioka, D., & Hirata, I. (2009). Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. Anticancer research, 29(1), 337-341.
Tahara, Tomomitsu ; Arisawa, Tomiyasu ; Shibata, Tomoyuki ; Yamashita, Hiromi ; Yoshioka, Daisuke ; Hirata, Ichiro. / Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. In: Anticancer research. 2009 ; Vol. 29, No. 1. pp. 337-341.
@article{48ef7a6c647749b89919e2c7df53cb43,
title = "Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis",
abstract = "Background: The altered expression of multidrug resistance 1 (MDR1) contributes to various types of carcinogenesis and their disease progression. Hypermethylation of CpG islands located in the promoter regions is involved in gene silencing at the transcriptional level. The methylotion status of MDR1 gene promoter was investigated in gastric cancer in relation to various clinicopathological features. Patients and Methods: The methylation of the MDR1 promoter was estimated in both antral non-neoplastic mucosa and cancer lesions in 83 patients with gastric cancer using a methylation-specific PCR method. Results: The methylation ratio (MR) of the cancer lesions (31.3±20.5) was significantly higher than that of non non-neoplastic mucosa (20.9±31.3, p=0.0004). The MR was especially high in Lauren's intestinal cancer (p<0.0001). A higher MR was also observed in more advanced stage (p=0.005) and lymph vessel invasion-positive cases (p=0.002). Conclusion: The promoter methylation of MDR1 seems to have a significant role in carcinogenesis and tumor progression in the stomach.",
author = "Tomomitsu Tahara and Tomiyasu Arisawa and Tomoyuki Shibata and Hiromi Yamashita and Daisuke Yoshioka and Ichiro Hirata",
year = "2009",
month = "1",
day = "1",
language = "English",
volume = "29",
pages = "337--341",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

Tahara, T, Arisawa, T, Shibata, T, Yamashita, H, Yoshioka, D & Hirata, I 2009, 'Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis', Anticancer research, vol. 29, no. 1, pp. 337-341.

Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. / Tahara, Tomomitsu; Arisawa, Tomiyasu; Shibata, Tomoyuki; Yamashita, Hiromi; Yoshioka, Daisuke; Hirata, Ichiro.

In: Anticancer research, Vol. 29, No. 1, 01.01.2009, p. 337-341.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis

AU - Tahara, Tomomitsu

AU - Arisawa, Tomiyasu

AU - Shibata, Tomoyuki

AU - Yamashita, Hiromi

AU - Yoshioka, Daisuke

AU - Hirata, Ichiro

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Background: The altered expression of multidrug resistance 1 (MDR1) contributes to various types of carcinogenesis and their disease progression. Hypermethylation of CpG islands located in the promoter regions is involved in gene silencing at the transcriptional level. The methylotion status of MDR1 gene promoter was investigated in gastric cancer in relation to various clinicopathological features. Patients and Methods: The methylation of the MDR1 promoter was estimated in both antral non-neoplastic mucosa and cancer lesions in 83 patients with gastric cancer using a methylation-specific PCR method. Results: The methylation ratio (MR) of the cancer lesions (31.3±20.5) was significantly higher than that of non non-neoplastic mucosa (20.9±31.3, p=0.0004). The MR was especially high in Lauren's intestinal cancer (p<0.0001). A higher MR was also observed in more advanced stage (p=0.005) and lymph vessel invasion-positive cases (p=0.002). Conclusion: The promoter methylation of MDR1 seems to have a significant role in carcinogenesis and tumor progression in the stomach.

AB - Background: The altered expression of multidrug resistance 1 (MDR1) contributes to various types of carcinogenesis and their disease progression. Hypermethylation of CpG islands located in the promoter regions is involved in gene silencing at the transcriptional level. The methylotion status of MDR1 gene promoter was investigated in gastric cancer in relation to various clinicopathological features. Patients and Methods: The methylation of the MDR1 promoter was estimated in both antral non-neoplastic mucosa and cancer lesions in 83 patients with gastric cancer using a methylation-specific PCR method. Results: The methylation ratio (MR) of the cancer lesions (31.3±20.5) was significantly higher than that of non non-neoplastic mucosa (20.9±31.3, p=0.0004). The MR was especially high in Lauren's intestinal cancer (p<0.0001). A higher MR was also observed in more advanced stage (p=0.005) and lymph vessel invasion-positive cases (p=0.002). Conclusion: The promoter methylation of MDR1 seems to have a significant role in carcinogenesis and tumor progression in the stomach.

UR - http://www.scopus.com/inward/record.url?scp=61449226555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449226555&partnerID=8YFLogxK

M3 - Article

C2 - 19331170

AN - SCOPUS:61449226555

VL - 29

SP - 337

EP - 341

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -

Tahara T, Arisawa T, Shibata T, Yamashita H, Yoshioka D, Hirata I. Effect of promoter methylation of multidrug resistance 1 (MDR1) gene in gastric carcinogenesis. Anticancer research. 2009 Jan 1;29(1):337-341.